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Abstract
The detection and identification of microorganisms circulating in the bloodstream of patients is arguably one of the most important
functions of the clinical microbiology laboratory. Effective implementation of this function requires careful consideration of specimen
collection and processing, culture techniques, result reporting, and, perhaps most importantly, result interpretation by the physician. The
purpose of this review is to provide a synopsis of the current state of the art for each of these areas, with the intention of providing
adequate information to enable clinical laboratory personnel and physicians to critically evaluate and, if required, improve their current
blood culture practices.
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Introduction
Bloodstream infections (BSIs) represent an important cause of
human morbidity and mortality. The evaluation of patients
suspected of having a BSI routinely includes blood cultures,
which optimally yield an aetiological diagnosis and provide the
opportunity to perform antimicrobial susceptibility testing to
guide therapeutic intervention when necessary. The clinical
significance of positive blood cultures has been extensively
evaluated over the past several decades [1–6]. These studies
have served to define the most frequent aetiological agents
responsible for BSIs and the range of agents, and have
improved our understanding of the risks and outcomes
associated with such infections. As the baseline characteristics
of patients have changed with advances in medicine (e.g. more
immunocompromised hosts, more indwelling catheters and
other intravascular devices, and changes in therapy for human
immunodeficiency virus), the epidemiology of BSIs has also
evolved, with more infections occurring in patients with
intravascular devices and in outpatient settings [5]. Addition-
ally, there appears to be a trend towards improved outcomes
in patients with BSIs, perhaps as a consequence of earlier
therapeutic intervention, whereas the number of BSIs appears
to be increasing, especially those occurring in populations that
were previously less affected (outpatients).
Because BSIs remain an important cause of morbidity and
mortality, and prompt targeted therapeutic intervention may
improve patient outcomes, there has been significant interest
in improving the speed and accuracy of blood culture methods
in the clinical microbiology laboratory. Despite these efforts,
little has changed since the introduction of continuous-
monitoring blood culture systems in the 1990s, but incremen-
tal advances in more rapid identification and susceptibility
prediction have occurred, especially for some particularly
troublesome pathogens. Moreover, greater advances appear
to be on the horizon.
Blood Culture Collection
The utility of blood culture for detecting BSI is directly
influenced by the collection of optimal specimens only from
patients with clinical findings compatible with BSI; routine
‘surveillance’ blood cultures are costly and of little clinical value
[7–9]. Clearly, venipuncture is the preferred method for blood
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culture collection. Arterial blood samples do not increase
diagnostic yield, and blood specimens obtained from intravas-
cular lines have demonstrated increased rates of contamina-
tion in some studies [10]. The American College of Physicians
guidelines recommend that collecting blood for culture from
intravascular devices be avoided, and the CLSI recommends
that, if one must collect a blood culture from an intravenous
line, it should be paired with a culture that is obtained via
venipuncture to assist in the interpretation of positive results
[11,12]. The timing of blood culture collection does not appear
to significantly affect the recovery of clinically relevant
microorganisms, and most authorities therefore recommend
collecting multiple sets simultaneously or over a short period
of time, except when documentation of continuous bactera-
emia is required for patients with endovascular infection
[12,13]. Whenever possible, two to four sets of blood
specimens should be collected from independent venipuncture
sites, and, for adult patients, each set should consist of 20–
40 mL of blood [12–15]. The volume of blood drawn from
infants and children is less well prescribed, but should be based
on the child’s age and not exceed 1% of the patient’s total
blood volume [12,16]. It is clear that the total volume of blood
cultured from adult patients is directly proportional to the
yield of microorganisms recovered. This is a consequence of
the fact that most adult patients with BSIs have very low
circulating concentrations of viable microorganisms. Inade-
quate blood volume or the collection of a single blood culture
set significantly reduces the sensitivity of the test, and also
makes the interpretation of results far more difficult
[13,15,17,18]. Collection of multiple sets of blood cultures
from a single venipuncture or intravascular line should also be
avoided. For optimal recovery of diverse BSI aetiological
agents, each set of blood cultures should include paired
aerobic and anaerobic blood culture bottles, and the aerobic
bottle should be filled first [12,19,20].
Proper skin antisepsis prior to collection of blood cultures via
peripheral venipuncture is paramount, to reduce blood culture
contamination rates and facilitate result interpretation for the
clinician. A variety of skin disinfectants have been clinically
evaluated, and reports comparing their relative efficacy have
been published [21–25]. On the basis of these data, current
guidance documents conclude that tincture of iodine, chlorine
peroxide and chlorhexidine gluconate are superior to povidine-
iodine preparations, and that tincture of iodine and chlorhex-
idine gluconate are probably equivalent for skin antisepsis prior
to blood culture collection [12]. Although chlorhexidine
gluconate is an adequate disinfectant for older infants, children,
and adults, it should not be used on infants <2 months of age,
and an alternative is therefore required in centres where this
disinfectant is otherwise routinely employed.
Once optimal blood culture specimens are collected
according to the principles outlined above, they should be
sent to the laboratory as promptly as possible. These
specimens should never be refrigerated or frozen, and should
be held at room temperature for no more than a few hours if
necessary. Although an extended delay between blood culture
collection and incubation in a continuous-monitoring blood
culture instrument is not recommended, a significant diminu-
tion in pathogen recovery has only been experimentally
observed when blood culture bottles have been held for
>24 h at 4°C or room temperature and for >12 h at 37°C
[26]. Lengthy incubation of blood culture bottles prior to
entering them into a continuous-monitoring blood culture
instrument may delay or impede the detection of growth by
the instrument, and is discouraged.
Laboratory Techniques for Blood Culture
In the vast majority of institutions, most blood culture
specimens delivered to the laboratory are entered into an
incubation protocol on a continuously monitored blood
culture device. There are several manufacturers of such
devices, and their performance characteristics are similar [27–
35]. These devices incubate the blood culture bottles for a
prescribed period of time (determined by the user) and signal
audibly and/or visually if growth is detected.
Each automated blood culture system has its own associ-
ated medium formulations that must be selected by the user.
The blood culture bottles typically contain proprietary
mixtures of culture medium, an anticoagulant, and, in many
cases, resins or charcoal mixtures to reduce the effects of
antimicrobials and other toxic compounds. Generally, combi-
nations of medium formulations that are complementary to
each other are chosen to enhance the recovery of the most
diverse range of microorganisms. Medium combinations typ-
ically include aerobic and anaerobic formulations and, in select
circumstances, a formulation containing reagents that are ideal
for recovering mycobacteria and/or yeasts may be inoculated
as well. Controlled studies comparing the performance of
media with and without the addition of antimicrobial binding
or absorbing agents (resins and/or charcoal compounds) have
repeatedly demonstrated that the latter formulations are
clearly superior for the recovery of microorganisms, especially
staphylococci and yeasts [29,34–37].
Blood cultures entered into automated, continuous-moni-
toring protocols should routinely be incubated for 5 days.
Multiple studies have shown that this incubation time is
adequate for the detection of the majority of pathogens,
including fastidious bacteria that belong to the Haemophilus,
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Actinobacillus, Cardiobacterium, Eikinella and Kingella (HACEK)
group, and that incubation beyond 5 days increases the
number of contaminants recovered [38–43]. Longer incuba-
tion times may be required when dimorphic fungaemia or
bacteraemia caused by Legionella, Brucella, Bartonella or Nocar-
dia spp. is suspected. Blood cultures for Mycobacterium spp.
should be incubated for 4 weeks.
The detection of some microorganisms is enhanced by
employing blood culture techniques in addition to or in place
of standard instrumented blood culture systems. The most
common example of this principle is the utilization of the
Isolator blood culture system (Wampole Laboratories, Cran-
bury, NJ, USA) for the enhanced detection of dimorphic fungi
and Bartonella spp. [44–46]. This system is unique in that it is
non-broth-based. Instead, blood samples obtained by veni-
puncture are collected into a tube that contains a lysing
solution. The tubes are then transported to the laboratory,
where they are centrifuged. The supernatant is discarded, and
the pellet is inoculated onto solid medium, the composition of
which may be tailored to recover the organisms (bacteria,
fungi, and/or mycobacteria) that are most likely or highly
suspected on the basis of clinical findings. Although there are
clear advantages to using this approach in select circumstances
(suspicion of BSI caused by dimorphic fungi or Bartonella spp.),
it is not routinely employed, as it is quite labour-intensive, it
poses a greater risk of laboratory-acquired infection to
technologists, and it is inferior to standard blood culture
methods for the detection of anaerobes, Haemophilus spp., and
pneumococci [47–50].
Special Considerations for Select Microor-
ganisms
Fungal blood cultures
Fungi represent an emerging group of organisms that are
responsible for BSI with increasing frequency. The growth
requirements for fungi often differ from those for bacteria,
most notably with regard to optimal growth temperature and
media. For example, most yeasts grow best at 37°C, whereas
filamentous fungi often grow best at lower (27–30°C)
temperatures. Most routine manual and automated blood
culture systems are able to support the growth of yeasts such
as Candida spp. However, if suspicion is high for a BSI being
caused by yeast, and routine blood cultures are negative, then
it may be reasonable to consider a request for alternative test
methods that are optimally designed to support the growth of
most yeasts. Moulds, and especially dimorphic fungi, often
grow poorly in typical instrumented blood culture systems.
Furthermore, the recovery of moulds such as Aspergillus spp. is
often of unclear clinical significance when they are isolated
with these methods [51]. In cases where fungaemia caused by a
mould is suspected, alternative blood culture methods should
be employed, such as the lysis centrifugation method, in which
the lysed and pelleted blood specimen can be plated on
medium that specifically supports the growth of moulds and
dimorphic fungi. Some fungi require highly specialized medium
supplements, the most noteworthy example being the
requirement for lipid supplementation for Malasezzia furfur,
which is often achieved by overlaying fungal medium with olive
oil.
Mycobacterial blood cultures
Mycobacterial BSIs occur in immunocompromised patients
(either as a consequence of iatrogenic immunosuppression, or
associated with an immunosuppressive condition) and patients
with long-term vascular access devices. Investigation tailored
to the recovery of mycobacterial blood isolates should thus
generally be limited to patients with such characteristics.
As mycobacteria are commonly located intracellularly,
approaches to growing them in vitro often include lysis of
leukocytes prior to incubation in a rich medium that contains
fatty acids. Mycobacteria may be optimally recovered, with
extended incubation of 4 weeks, with manual methods such as
lysis centrifugation or the use of commercial ‘lytic’ media in
manual or instrumented systems. These blood culture formu-
lations typically contain a proprietary mixture of fatty acids
that support mycobacterial growth, along with antimicrobial
agents. Limited comparisons between formulations suggest
some variability in the performance of lytic culture media, but
comprehensive comparative studies of all formulations have
not been performed [52–56].
Fastidious microorganisms
Fastidious microorganisms are rarely implicated in BSI in
clinical practice, but when they are isolated from blood
cultures they often represent serious infection. In some cases,
the observation of signal-positive Gram stain-negative blood
culture results provides a clue that a fastidious microorganism
might be implicated as the BSI aetiological agent. In those
cases, collaboration between the laboratory and clinician is
essential to ensure that appropriate steps are taken to increase
the odds of isolation of such organisms. Some organisms may
be small or of unusual morphology, and not readily recognized
by the technologist. In other cases, the organism may not stain
well with standard Gram stain protocols (e.g. Mycoplasma and
Campylobacter). In those cases, alternative staining techniques
may be employed, including the use of acridine orange (to stain
bacterial nucleic acids) or the use of carbol fuschin as an
alternative to safranin as a counterstain in the Gram stain
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protocol to enhance the staining of Campylobacter, Helicobacter,
and Brucella.
Perhaps the most frequently encountered fastidious bacte-
ria are the members of the HACEK group as the aetiological
agents for subacute bacterial endocarditis. As noted above, in
the vast majority of cases, these organisms are isolated with
standard blood culture techniques without the need for special
protocols or procedures. This is also generally true for Brucella
spp., Campylobacter spp., and Francisella spp., but is not true for
all fastidious bacteria.
Abiotrophia and Granulicatella are usually detected with
automated blood culture instruments, but do not grow well
on standard, unsupplemented solid media, as they require
pyridoxal or cysteine for growth. This can be accomplished by
co-cultivation with staphylococci, by the use of pyridoxal-
impregnated disks placed on the surface of standard blood agar
plates, or by the use of specially supplemented or enriched
media.
The yield of standard blood culture media for the cultivation
of Bartonella spp. is typically low. Special techniques, including
lysis centrifugation methods and/or serological investigations,
are thus indicated for the diagnosis of BSI caused by Bartonella
spp.
Legionella spp. require buffered charcoal yeast extract
(BCYE) for optimal growth. Recovery of Legionella can be
achieved by subculturing standard blood culture medium that
has been incubated according to the standard protocol for
5 days into BCYE, or by utilizing BCYE in conjunction with
lysis centrifugation methods. A detailed description of all of the
special techniques required for the culture of other rarely
encountered fastidious organisms (e.g. Helicobacter and Lepto-
spira) is beyond the scope of this review, and has been
provided elsewhere [12].
Isolation, Identification, and Susceptibility
Testing
Once blood cultures become positive for growth, either by
manual subculture techniques or signalling from automated
systems, a Gram stain is performed. A positive Gram stain
result should be regarded as a critical value, and immediately
phoned to the ordering clinician or another responsible
member of the healthcare team providing care to the patient.
Subcultures are performed at this point, and these allow
identification and, if indicated, susceptibility testing to be
performed, typically over the next 24–48 h.
Laboratories should have a comprehensive protocol in
place to guide the appropriate work-up of organisms isolated
from blood cultures. To optimally utilize resources, complete
organism identification and organism-specific susceptibility
testing should only be performed on clinically important
isolates, and not on organisms that probably represent
contaminants [57,58]. Isolates that are probably associated
with true BSI (as per the laboratory protocol) should be saved
in the laboratory (by serial subculture) for several days to
allow additional testing if required, and may be retained for
longer periods of time (in a frozen archive) to allow
investigation of recurrent BSIs in appropriate patients.
Interpretation of Positive Blood Cultures
The interpretation of positive blood culture results is often
straightforward, but sometimes presents a significant dilemma
for physicians and clinical microbiologists. For the latter
circumstance, a variety of laboratory data must be evaluated in
the context of the clinical picture to arrive at an accurate
interpretation. The pattern of positivity of blood cultures is
often useful; when the majority of or all blood culture sets
obtained by independent venipuncture are positive for the same
microorganism, the likelihood that this represents true BSI is
exceedingly high, regardless of the organism’s identity [2].
Likewise, the identities of organisms isolated frompositive blood
cultures also have value. Staphylococcus aureus, Streptococcus
pneumoniae, Enterobacteriaceae, Pseudomonas aeruginosa and
Candida albicans are almost always predictive of true BSI.
Conversely, Corynebacterium spp. and Propionibacterium spp.
almost always represent contamination. The recovery of
viridans group streptococci, coagulase-negative staphylococci
(CoNS) and enterococci is more difficult to interpret, as some
studies have demonstrated that they represent true BSI in 38%,
15% and 78% of cases, respectively [1]. Notably, CoNS
represent one of the most commonly encountered blood
culture contaminants, but also constitute an important cause of
BSI in the ever-expanding population of patients with implanted
devices and indwelling catheters. Interpretation for these cases
may be aided by identifyingCoNS to the species level whenmore
than one set of blood cultures becomes positive. If the same
species of CoNS is isolated frommultiple blood culture sets, the
odds that it represents true bacteraemia as opposed to
contamination increase [3].Without this additional information,
using the number of positive blood culture sets that are
generically positive for CoNS is a less reliable predictor. Finally,
some have suggested that the number of blood culture bottles
(as opposed to the number of sets) has predictive value, in that
themore that are positive for CoNS, themore likely it is that the
patient has bacteraemia caused by CoNS. However, systematic
evaluations of this approach have proven it to be unreliable
[18,59].
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Rapid Methods for Identification and
Susceptibility Testing of Isolates from
Positive Blood Cultures
Prompt detection, identification and susceptibility testing of
the aetiological agents responsible for BSIs is critical, as it
allows clinicians to make the most informed decisions about
possible therapeutic interventions. Blood cultures incubated in
modern instrumented systems that are ultimately positive for
most bacterial pathogens typically signal positive in a median
time of 12–36 h, whereas the time to positivity from collection
to detection is longer for some fastidious bacteria, anaerobes,
and fungi [28,29]. Following detection, Gram stain rapidly
provides some information to the clinician that may be useful
for determining the significance of the positive result and/or
determining initial antimicrobial therapy. Standard microbio-
logical protocols that rely on biochemical identification of
microorganisms plus phenotypic antimicrobial susceptibility
testing follow, and may take an additional 48–72 h, assuming
that the results obtained are easily interpreted. It may take
days longer to generate final results for organisms that are
difficult to identify biochemically or grow slowly in vitro. Given
the usual delay of 3–5 days from the collection of blood
cultures to the time at which final identification and suscep-
tibility results are obtained, there has been keen interest in
reducing this interval by employing a variety of rapid methods.
In some cases, the time to delivery of results may be reduced
by employing traditional microbiological protocols earlier in
the work-up. For example, the coagulase test, which is
traditionally used to distinguish CoNS isolates from coagu-
lase-positive isolates, may be performed directly on signal-
positive blood culture broths that show Gram-positive cocci in
clusters on Gram staining [60]. This approach allows rapid
distinction between CoNS and coagulase-positive staphylo-
cocci (which are mostly S. aureus), and may influence the
ability of clinicians to interpret the clinical significance of a
positive blood culture result and their ability to begin
appropriate antimicrobial therapy. Obviously, this is not a
complete solution, as it does not definitively identify the
organism and nor does it provide susceptibility information. To
augment such an approach, some laboratories may couple
direct coagulase testing with the use of chromogenic agar
medium, which allows identification of methicillin-resistant
S. aureus isolates within 18–24 h [61]. Clearly, this solution
represents an improvement over traditional methods, but
applies only to one specific organism and gives susceptibility
results for only one drug.
More robust approaches to improving the turn-around
time for the laboratory diagnosis of BSIs have focused largely
on newer or novel technology. Molecular methods, including
nucleic acid amplification assays (NAATs), DNA sequencing
approaches, DNA microarrays, and probe hybridization, have
emerged as useful tools for microorganism identification, and,
in some cases, the prediction of antimicrobial susceptibility
for select antibiotics [62–66]. Novel phenotypic approaches
have also been shown to reduce turn-around time for the
identification and limited susceptibility testing of select
organisms (Kirn et al., IDSA Annual Meeting, 2011). Finally,
matrix-assisted laser desorption ionization time-of-flight mass
spectrometry, which has already demonstrated widespread
utility in the routine identification of microorganisms in the
clinical microbiology laboratory, appears to be a very
promising approach to the rapid identification of organisms
directly from signal-positive blood culture broths [67]. The
major drawback of this approach, like most of the others, is
the lack of rapid susceptibility information to accompany the
organism identity. It is not yet clear when or if this capability
will be possible with matrix-assisted laser desorption ioniza-
tion time-of-flight mass spectrometry or other rapid methods,
and the actual clinical utility of microorganism identification in
the absence of susceptibility information is narrow and
unproven.
Rapid Methods for Detection of
Microorganisms Directly in Blood Specimens
Although technological improvements have led to reductions
in the time required for identification and (in limited cases)
susceptibility testing of isolates from signal-positive blood
cultures, a further improvement would obviously be the ability
to rapidly and directly detect and identify microorganisms in
blood samples from patients with a suspected BSI. Currently
available solutions involve the use of NAATs that are designed
to detect specific microorganisms in blood samples [68].
Controlled trials evaluating the performance of such solutions
as compared with standard blood cultures have demonstrated
reasonably good performance, with the obvious limitation that
NAATs will only detect a subset of possible BSI pathogens,
and provide no susceptibility information [68,69]. As conven-
tional phenotypic susceptibility testing requires isolated
organisms, if the direct NAAT is positive and the correspond-
ing culture is negative, susceptibility information may never be
available. Thus, at the present time, such an approach may
serve only as an adjunct to standard of care protocols. As is
the case for rapid methods for blood culture isolate identi-
fication, the actual clinical impact of rapid methods for direct
pathogen detection in blood specimens has not been exten-
sively studied.
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Conclusions
Technological advances have resulted in the ability to more
rapidly identify and, in some cases, predict the susceptibility of
the aetiological agents of BSIs to a limited extent. Although
these methods hold great promise for the future, conventional
blood culture methods remain the dominant approach to
diagnosing most patients with BSIs. Therefore, the traditional
principles of patient selection, adequate and careful specimen
collection, appropriate cultivation and accurate result inter-
pretation remain critical to the delivery of the most effective
care for our patients with suspected BSIs.
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